LA JOLLA PHARMACEUTICAL CO 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed May 20, 2005
Insider Transaction Report
Form 4
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
- Award
Stock Option (right to buy)
2005-05-19$0.43/sh+37,235$16,011→ 110,000 totalExercise: $0.00Exp: 2015-05-19→ Common Stock (37,235 underlying)
Holdings
- 6,497
Common Stock
- 787,169(indirect: By Trust)
Stock Option (right to buy)
Exercise: $0.00→ Common Stock
Footnotes (2)
- [F1]The stock options vest and become exercisable monthly over the next three years. In the event employee is terminated without cause or there is a change in control of the Company and employee's employment is terminated in connection with such change in control, the options automatically vest as of the date of employee's termination and remain exercisable for a period of one year following the date of termination.
- [F2]Reporting only indirect holdings, no transaction data is necessary